tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eliana Merle, 73 are a BUY (80.22%), 18 are a HOLD (19.78%).
Analyst Eliana Merle, currently employed at UBS, carries an average stock price target met ratio of 47.49% that have a potential upside of 44.55% achieved within 179 days.
Eliana Merle’s has documented 194 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ZNTL, Zentalis Pharmaceuticals Llc at 20-Jun-2024.
Analyst best performing recommendations are on ANAB (ANAPTYSBIO).
The best stock recommendation documented was for ANAB (ANAPTYSBIO) at 11/7/2019. The price target of $28 was fulfilled within 1 day with a profit of $8.16 (22.57%) receiving and performance score of 225.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
77
$39.02 (102.74%)
90
9 days ago
1/4 (25%)
$37.51 (94.99%)
24
Buy
92
$54.02 (142.23%)
92
1 months 28 days ago
3/17 (17.65%)
$51.44 (126.82%)
108
Hold
48
$10.02 (26.38%)
62
2 months 3 days ago
7/8 (87.5%)
$8.32 (20.97%)
65
Buy
85
$47.02 (123.80%)
85
2 months 18 days ago
10/14 (71.43%)
$42.7 (100.95%)
230
Buy
85
$47.02 (123.80%)
89
2 months 18 days ago
5/7 (71.43%)
$42.7 (100.95%)
391
Which stock is Eliana Merle is most bullish on?
Which stock is Eliana Merle is most reserved on?
What Year was the first public recommendation made by Eliana Merle?
